Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Tassi, Renata A ^a   Calza, Stefano ^a   Ravaggi, Antonella ^a   Bignotti, Eliana ^a   Odicino, Franco E ^a   Tognon, Germana ^a   Donzelli, Carla ^a   Falchetti, Marcella ^a   Rossi, Elisa ^a   Todeschini, Paola ^a   Romani, Chiara ^a   Bandiera, Elisabetta ^a   Zanotti, Laura ^a   Pecorelli, Sergio ^a   Santin, Alessandro D ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMAGLOBIN; MAMMAGLOBIN B; MESSENGER RNA; UNCLASSIFIED DRUG; MYELIN PROTEIN; PROTEOLIPID; PROTEOLIPID PROTEIN; TUMOR MARKER; UTEROGLOBIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPITHELIAL OVARIAN CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RISK REDUCTION; BIOSYNTHESIS; EPITHELIUM; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PHYSIOLOGY; RECURRENT DISEASE; RISK;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYELIN PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROTEOLIPIDS; RECURRENCE; RISK; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 68949199668     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-253     Document Type: Article

References (34)

1. Jemal A Siegel R Ward E Hao Y Xu J Murray T Thun MJ Cancer statistics, 2008 CA Cancer J Clin 2008, 58:71-96 10.3322/CA.2007.0010 18287387
2. Baak JP Wisse-Brekelmans EC Langley FA Talerman A Delemarre JF Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours Journal of Clinical Pathology 1986, 39:1340-1346 1140799 3805319 10.1136/jcp.39.12.1340
3. Kosary CL FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin Surg Oncol 1994, 10:31-46 10.1002/ssu.2980100107 8115784
4. Canevari S Gariboldi M Reid JF Bongarzone I Pierotti MA Molecular predictors of response and outcome in ovarian cancer Crit Rev Oncol Hematol 2006, 60:19-37 10.1016/j.critrevonc.2006.03.003 16829123
5. Bignotti E Tassi RA Calza S Ravaggi A Romani C Rossi E Falchetti M Odicino FE Pecorelli S Santin AD Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy Gynecol Oncol 2006, 103:405-416 10.1016/ j.ygyno.2006.03.056 16725184
6. Becker RM Darrow C Zimonjic DB Popescu NC Watson MA Fleming TP Identification of mammaglobin B, a novel member of uteroglobin gene family Genomics 1998, 54:70-78 10.1006/geno.1998.5539 9806831
7. Ni J Kalff-Suske M Gentz R Schageman J Beato M Klug J All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster Ann NY Acad Sci 2000, 923:25-42 11193762
8. Muller-Schottle F Classen-Linke I Beier-Hellwig K Sterzik K Beier HM Uteroglobin expression and release in the human endometrium Ann NY Acad Sci 2000, 923:332-335 11193772
9. Stoeckelhuber M Messmer EM Schmidt C Xiao F Schubert C Klug J Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues Histochem Cell Biol 2006, 126:103-109 10.1007/s00418-005-0137-2 16395610
10. Xiao F Mirwald A Papaioannou M Baniahmad A Klug J Secretoglobin 2A1 is under selective androgen control mediated by a peculiar binding site for Sp family transcription factors Mol Endocrinol 2005, 19:2964-2978 10.1210/me.2004-0408 16020486
11. Sjödin A Guo D Lund-Johansen M Krossnes BK Lilleng P Henriksson R Hedman H Secretoglobins in the human pituitary: High expression of lipophilin B and its down-regulation in pituitary adenomas Acta Neuropathol (Berl) 2005, 109:381-386 10.1007/s00401-004-0972-6
12. Nissan A Jager D Roystacher M Prus D Peretz T Eisenberg I Freund HR Scanlan M Ritter G Old LJ Mitrani-Rosenbaum S Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients Br J Cancer 2006, 94:681-685 16495929
13. Ouellette RJ Richard D Maïcas E RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes Am J Clin Pathol 2004, 121:637-643 Erratum in: Am J Clin Pathol 2004, 122:813 10.1309/MMACTXT55L8QTKC1 15151203
14. Denninghoff V Allende D Paesani F Garcia A Avagnina A Perazzo F Abalo E Crimi G Elsner B Sentinel Lymph Node Molecular Pathology in Breast Carcinoma Diagn Mol Pathl 2008, 17:214-219 10.1097/PDM.0b013e3181601777
15. Sjödin A Guo D Sørhaug S Bjermer L Henriksson R Hedman H Dysregulated secretoglobin expression in human lung cancers Lung Cancer 2003, 41:49-56 10.1016/S0169-5002(03)00126-0 12826312
16. Aihara T Fujiwara Y Miyake Y Okami J Okada Y Iwao K Sugita Y Tomita N Sakon M Shiozaki H Monden M Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers Cancer Lett 2000, 150:79-84 10.1016/S0304-3835(99)00378-X 10755390
17. Okami J Dohno K Sakon M Iwao K Yamada T Yamamoto H Fujiwara Y Nagano H Umeshita K Matsuura N Nakamori S Monden M Genetic detection for micrometastasis in lymph node of biliary tract carcinoma Clin Cancer Res 2000, 6:2326-2332 10873083
18. Tassi RA Bignotti E Rossi E Falchetti M Donzelli C Calza S Ravaggi A Bandiera E Pecorelli S Santin AD Overexpression of mammaglobin B in epithelial ovarian carcinomas Gynecol Oncol 2007, 105:578-585 10.1016/ j.ygyno.2007.01.043 17343903
19. Tassi RA Bignotti E Falchetti M Calza S Ravaggi A Rossi E Martinelli F Bandiera E Pecorelli S Santin AD Mammaglobin B expression in human endometrial cancer Int J Gynecol Cancer 2008, 18:1090-1096 10.1111/ j.1525-1438.2007.01137.x 18021217
20. Santin AD Zhan F Bellone S Palmieri M Cane S Bignotti E Anfossi S Gokden M Dunn D Roman JJ O'Brien TJ Tian E Cannon MJ Shaughnessy J Jr Pecorelli S Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy Int J Cancer 2004, 112:14-25 10.1002/ijc.20408 15305371
21. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods 2001, 25:402-408 10.1006/meth.2001.1262 11846609
22. Van Buuren S Oudshoorn K Flexible multivariate imputation by MICE TNO-rapport PG 99.054 TNO Prevention and Health Leiden, The Netherlands 1999
23. Austin PC Tu JV Bootstrap methods for developing predictive models Am Stat 2004, 58:131-137 10.1198/0003130043277
24. Heymans MW van Buuren S Knol DL van Mechelen W de Vet HC Variable selection under multiple imputation using the bootstrap in a prognostic study BMC Med Res Methodol 2007, 13(7):33 10.1186/1471-2288-7-33
25. R: A language and environment for statistical computing http://www.R-project.org
26. Heagerty PJ Lumley T Pepe MS Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 2000, 56:337-344 10.1111/j.0006-341X.2000.00337.x 10877287
27. Ooka M Sakita I Fujiwara Y Tamaki Y Yamamoto H Aihara T Miyazaki M Kadota M Masuda N Sugita Y Iwao K Monden M Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients Oncol Rep 2000, 7:561-566 10767368
28. Aihara T Fujiwara Y Ooka M Sakita I Tamaki Y Monden M Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction Breast Cancer Res Treat 1999, 58:137-140 10.1023/A:1006335817889 10674878
29. Fiegl M Haun M Massoner A Krugmann J Müller-Holzner E Hack R Hilbe W Marth C Duba HC Gastl G Grünewald K Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/ mammaglobin B expression improves diagnosis of malignant effusions J Clin Oncol 2004, 22:474-483 10.1200/JCO.2004.06.063 14752070
30. Núñez-Villar MJ Martínez-Arribas F Pollán M Lucas AR Sánchez J Tejerina A Schneider J Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype Breast Cancer Res 2003, 5:R65-70 165002 12793902 10.1186/bcr587
31. Span PN Waanders E Manders P Heuvel JJ Foekens JA Watson MA Beex LV Sweep FC Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time J Clin Oncol 2004, 22:691-698 10.1200/JCO.2004.01.072 14966093
32. Guan XF Hamedani MK Adeyinka A Walker C Kemp A Murphy LC Watson PH Leygue E Relationship between mammaglobin expression and estrogen receptor status in breast tumors Endocrine 2003, 21:245-250 10.1385/ ENDO:21:3:245 14515009
33. Sjödin A Ljuslinder I Henriksson R Hedman H Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation Anticancer Res 2008, 28:1493-8 18630503
34. Mukherjee AB Zhang Z Chilton BS Uteroglobin: A steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily Endocr Rev 2007, 28:707-25 10.1210/er.2007-0018 17916741